IE
HCAT icon

Israel Englander’s Health Catalyst HCAT Stock Holding History

Israel Englander’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Buy
+516,083
New +$745K ﹤0.01% 4295
2026
Q1 		– Sell
-1,084,843
Closed -$2.59M – 5975
2025
Q4 		$2.59M Sell
1,084,843
-504,693
-32% -$1.38M ﹤0.01% 3717
2025
Q3 		$4.53M Buy
1,589,536
+1,528,710
+2,513% +$5.23M ﹤0.01% 3249
2025
Q2 		$229K Sell
60,826
-437,255
-88% -$1.72M ﹤0.01% 5305
2025
Q1 		$2.26M Sell
498,081
-1,487,611
-75% -$7.87M ﹤0.01% 3669
2024
Q4 		$14M Buy
1,985,692
+258,853
+15% +$2.06M 0.01% 1839
2024
Q3 		$14.1M Sell
1,726,839
-686,441
-28% -$4.96M 0.01% 1874
2024
Q2 		$15.4M Buy
2,413,280
+1,184,131
+96% +$7.6M 0.01% 1708
2024
Q1 		$9.26M Buy
1,229,149
+202,261
+20% +$1.85M ﹤0.01% 2268
2023
Q4 		$9.51M Buy
1,026,888
+776,968
+311% +$6.35M ﹤0.01% 2240
2023
Q3 		$2.53M Sell
249,920
-166,579
-40% -$1.99M ﹤0.01% 3343
2023
Q2 		$5.21M Sell
416,499
-1,178,776
-74% -$14M ﹤0.01% 2642
2023
Q1 		$18.6M Sell
1,595,275
-202,599
-11% -$2.58M 0.01% 1381
2022
Q4 		$19.1M Sell
1,797,874
-142,985
-7% -$1.38M 0.01% 1486
2022
Q3 		$18.8M Buy
1,940,859
+1,323,571
+214% +$17.5M 0.01% 1400
2022
Q2 		$8.95M Buy
617,288
+153,182
+33% +$2.61M 0.01% 2178
2022
Q1 		$12.1M Buy
464,106
+131,139
+39% +$3.72M 0.01% 1927
2021
Q4 		$13.2M Buy
332,967
+197,509
+146% +$9M 0.01% 1847
2021
Q3 		$6.77M Sell
135,458
-59,628
-31% -$3.25M ﹤0.01% 2533
2021
Q2 		$10.8M Sell
195,086
-73,790
-27% -$3.93M 0.01% 1807
2021
Q1 		$12.6M Buy
268,876
+40,966
+18% +$1.98M 0.01% 1539
2020
Q4 		$9.92M Buy
+227,910
New +$8.41M 0.01% 1744
2020
Q3 		– Sell
-180,875
Closed -$5.28M – 4599
2020
Q2 		$5.28M Buy
180,875
+147,867
+448% +$4.09M 0.01% 1716
2020
Q1 		$863K Buy
+33,008
New +$1.01M ﹤0.01% 2558
2019
Q4 		– Sell
-23,261
Closed -$735K – 4378
2019
Q3 		$735K Buy
+23,261
New +$916K ﹤0.01% 3036

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Israel Englander's HCAT Position: Q2 2026 in Review

Israel Englander opened a new position in Health Catalyst (HCAT) in Q2 2026: 516,083 shares worth $1.03M. The stake represents ﹤0.01% of the portfolio and ranks #4295 among its holdings. This is a return to the name: Israel Englander previously reported a position in HCAT as recently as Q4 2025.

Israel Englander first reported a position in HCAT in Q3 2019 and has held it in 25 quarters since. The position peaked at $19.1M in Q4 2022. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Israel Englander held 516,083 shares of Health Catalyst worth $1.03M as of Q2 2026.
  • Health Catalyst was a new Israel Englander position in Q2 2026.
  • Health Catalyst made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4295 holding.
  • Israel Englander first reported a position in Health Catalyst in Q3 2019 and has held it in 25 quarters since.
  • Israel Englander's Health Catalyst position peaked at $19.1M in Q4 2022.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.